Perrigo invests in Tarex® patented technology
Perrigo announced an exclusive licensing agreement with Highland Pharmaceuticals for its Tarex® methamphetamine blocking technology and the distribution rights of Zephrex-D® (pseudoephedrine HCI 30 mg). Zephrex-D® was developed using the Tarex® technology. September 27, 2016